Compare GH & MNSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GH | MNSO |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 5.8B |
| IPO Year | 2018 | 2020 |
| Metric | GH | MNSO |
|---|---|---|
| Price | $101.92 | $19.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 21 | 2 |
| Target Price | ★ $82.76 | $24.10 |
| AVG Volume (30 Days) | ★ 2.2M | 681.0K |
| Earning Date | 10-29-2025 | 11-20-2025 |
| Dividend Yield | N/A | ★ 3.35% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.98 |
| Revenue | $902,569,000.00 | ★ $2,795,603,723.00 |
| Revenue This Year | $34.72 | $27.64 |
| Revenue Next Year | $26.46 | $19.31 |
| P/E Ratio | ★ N/A | $19.99 |
| Revenue Growth | ★ 30.38 | 23.44 |
| 52 Week Low | $29.91 | $13.95 |
| 52 Week High | $112.43 | $27.71 |
| Indicator | GH | MNSO |
|---|---|---|
| Relative Strength Index (RSI) | 55.40 | 39.93 |
| Support Level | $100.21 | $19.29 |
| Resistance Level | $109.59 | $19.76 |
| Average True Range (ATR) | 4.22 | 0.38 |
| MACD | -1.65 | 0.06 |
| Stochastic Oscillator | 13.51 | 52.16 |
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
MINISO Group Holding Ltd is a value retailer offering a variety of trendy lifestyle products featuring IP design. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand, which is engaged in the Design, buying, and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying, and sale of pop toys. The company generates maximum revenue from the MINISO brand segment. Geographically, it derives a majority of its revenue from China.